Although this study needs to be validated within a prospective clinical trial, it revealed the opportunity for formulating an international and integrated HER2 diagnostic criteria in CRC, using NGS as a bridge between the two gold methods IHC and FISH. This evidence concerns the gene ERBB2 and colorectal carcinoma.